Jeltje Schulten
Darmstadt, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 08, 2026
First-line cetuximab + platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE.
Journal: Cancer reports (Hoboken, N.J.)
Published: September 16, 2022
Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy: DIRECT.
Journal: Cancer reports (Hoboken, N.J.)
Published: February 22, 2021
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 11, 2018
Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation.
Journal: Cancer treatment reviews
Published: August 21, 2017
Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck.
Journal: Frontiers in oncology
Published: January 17, 2017
Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA otolaryngology-- head & neck surgery
Published: July 09, 2016
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 21, 2016
Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 30, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026